We offer Salmeterol and Fluticasone Propionate Inhalers in the following strengths:
Salmeterol 50 mcg + Fluticasone Propionate 100 mcg
Salmeterol 50 mcg + Fluticasone Propionate 250 mcg
Salmeterol 50 mcg + Fluticasone Propionate 500 mcg
Salmeterol 25 mcg + Fluticasone Propionate 125 mcg
Salmeterol and Fluticasone Propionate is a fixed-dose combination inhaler used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD).
Salmeterol is a long-acting beta-agonist (LABA) that opens the airways by relaxing smooth muscles.
Fluticasone Propionate is a corticosteroid that reduces inflammation and swelling in the airways.
Together, they provide long-lasting symptom control, reduce airway hyper-responsiveness, and improve quality of life in patients with persistent asthma or moderate-to-severe COPD. This combination is particularly effective for patients who require dual maintenance therapy and is not intended for acute symptom relief.
Reduction of airway inflammation and prevention of asthma-related hospitalizations
Adults and Children ≥12 years: 1 inhalation twice daily (morning and evening), at least 12 hours apart
Children <12 years: Dosage must be determined by a pediatric specialist
Explore our diverse range of pharmaceutical manufacturing categories, designed to deliver high-quality, reliable, and innovative healthcare solutions across multiple dosage forms.
Corporate Office
Plot No. :46 First Floor, Industrial Area Phase-2, Chandigarh-160002, India.
Manufacturing Unit
Village Kondi, Post Thana, District Solan, Baddi 173205 Himachal Pradesh, India.
